The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-κB activity and T-cell activation
暂无分享,去创建一个
V. Lang | S. Lobato-Gil | F. Lopitz-Otsoa | R. Barrio | F. Aillet | M. Rodríguez | I. Egaña | M. Lopez-Mato | A. Dorronroso | J. Sutherland | C. Trigueros | J. Sutherland | M S Rodriguez | I Egaña | F Lopitz-Otsoa | F Aillet | M P Lopez-Mato | A Dorronroso | S Lobato-Gil | J D Sutherland | R Barrio | C Trigueros | V Lang | A. Dorronsoro | Rosa Barrio | Manuel S. Rodríguez | M. Rodriguez | Lang | Lopez-Mato Mp | F. Lopitz‐Otsoa
[1] Lin-Feng Chen,et al. NF-κB Is Essential for Induction of CYLD, the Negative Regulator of NF-κB , 2004, Journal of Biological Chemistry.
[2] S. Ghosh,et al. The NF-kappaB family of transcription factors and its regulation. , 2009, Cold Spring Harbor perspectives in biology.
[3] Qiaqing Wu,et al. Cloning and expression analysis of a novel mouse zinc finger protein gene Znf313 abundantly expressed in testis. , 2007, Journal of biochemistry and molecular biology.
[4] J. Baik,et al. ZNF313 is a novel cell cycle activator with an E3 ligase activity inhibiting cellular senescence by destabilizing p21WAF1 , 2013, Cell Death and Differentiation.
[5] Rudi Beyaert,et al. Expression, biological activities and mechanisms of action of A20 (TNFAIP3). , 2010, Biochemical pharmacology.
[6] T. Gilmore,et al. Introduction to NF-kappaB: players, pathways, perspectives. , 2006, Oncogene.
[7] N. Perkins. The Rel/NF-kappa B family: friend and foe. , 2000, Trends in biochemical sciences.
[8] R. Hay,et al. Nuclear retention of IkappaBalpha protects it from signal-induced degradation and inhibits nuclear factor kappaB transcriptional activation. , 1999, The Journal of biological chemistry.
[9] Christian Gieger,et al. Genome-wide association analysis identifies three psoriasis susceptibility loci , 2010, Nature Genetics.
[10] M. Karin,et al. NF‐κB and the link between inflammation and cancer , 2012, Immunological reviews.
[11] Noula Shembade,et al. Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling. , 2007, The EMBO journal.
[12] D. Payan,et al. A Novel E3 Ubiquitin Ligase TRAC-1 Positively Regulates T Cell Activation , 2005, The Journal of Immunology.
[13] R. Contreras,et al. The Zinc Finger Protein A20 Inhibits TNF-induced NF-κB–dependent Gene Expression by Interfering with an RIP- or TRAF2-mediated Transactivation Signal and Directly Binds to a Novel NF-κB–inhibiting Protein ABIN , 1999, The Journal of cell biology.
[14] N. Copeland,et al. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20 , 2008, Nature Immunology.
[15] N. Perkins. The Rel/NF-κB family: friend and foe , 2000 .
[16] N. Perkins,et al. Good cop, bad cop: the different faces of NF-κB , 2006, Cell Death and Differentiation.
[17] M. Tatham,et al. Detection of protein SUMOylation in vivo , 2009, Nature Protocols.
[18] Lin-Feng Chen,et al. NF-kappaB is essential for induction of CYLD, the negative regulator of NF-kappaB: evidence for a novel inducible autoregulatory feedback pathway. , 2004, The Journal of biological chemistry.
[19] G. van Loo,et al. Genetic relationships between A20/TNFAIP3, chronic inflammation and autoimmune disease. , 2011, Biochemical Society transactions.
[20] N. Perkins,et al. Good cop, bad cop: the different faces of NF-kappaB. , 2006, Cell death and differentiation.
[21] A. Ma,et al. Failure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient mice. , 2000, Science.
[22] Noula Shembade,et al. Regulation of NF-κB signaling by the A20 deubiquitinase , 2012, Cellular and Molecular Immunology.
[23] V. Lang,et al. Fyn membrane localization is necessary to induce the constitutive tyrosine phosphorylation of Sam68 in the nucleus of T lymphocytes. , 1999, Journal of immunology.
[24] P. Marynen,et al. T cell antigen receptor stimulation induces MALT1 paracaspase–mediated cleavage of the NF-κB inhibitor A20 , 2008, Nature Immunology.
[25] Matthew T Wheeler,et al. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses , 2004, Nature Immunology.
[26] V. Dixit,et al. 14-3-3 Proteins Associate with A20 in an Isoform-specific Manner and Function Both as Chaperone and Adapter Molecules* , 1996, The Journal of Biological Chemistry.
[27] Richard C Trembath,et al. Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis. , 2011, Human molecular genetics.
[28] M. Bijlmakers,et al. T-cell regulator RNF125/TRAC-1 belongs to a novel family of ubiquitin ligases with zinc fingers and a ubiquitin-binding domain. , 2008, The Biochemical journal.
[29] V. Lang,et al. Identification of the NF-κB inhibitor A20 as a key regulator for human adipogenesis , 2013, Cell Death and Disease.
[30] Pui-Yan Kwok,et al. Genomewide Scan Reveals Association of Psoriasis with IL-23 and NF-κB Pathways , 2008, Nature Genetics.
[31] Noula Shembade,et al. Essential role for TAX1BP1 in the termination of TNF‐α‐, IL‐1‐ and LPS‐mediated NF‐κB and JNK signaling , 2007 .
[32] R. Beyaert,et al. A20: Central Gatekeeper in Inflammation and Immunity* , 2009, Journal of Biological Chemistry.
[33] G. van Loo,et al. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology. , 2009, Trends in immunology.
[34] R. Beyaert,et al. A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis. , 2000, Biochemical pharmacology.
[35] D. Pennington,et al. Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[36] M. Schmitz,et al. Autoregulatory feedback loops terminating the NF-kappaB response. , 2009, Trends in biochemical sciences.
[37] D. Thomas,et al. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo. , 1996, Oncogene.
[38] R. Contreras,et al. A20, an inhibitor of cell death, self‐associates by its zinc finger domain , 1996, FEBS letters.
[39] Jill K Thompson,et al. Nuclear Retention of IκBα Protects It from Signal-induced Degradation and Inhibits Nuclear Factor κB Transcriptional Activation* , 1999, The Journal of Biological Chemistry.
[40] Noula Shembade,et al. The ubiquitin‐editing enzyme A20 requires RNF11 to downregulate NF‐κB signalling , 2009, The EMBO journal.